Concepedia

Dingzhou Li

DL

Statistics

Publications

21

Citations

691

H-Index

15

Active since

2001

Affiliations

Pfizer (United States)(Current)

University of Michigan

Université Paris Cité

Roche (Switzerland)

Novartis (Switzerland)

Dingzhou Li is an author at Pfizer (United States) specializing in pharmacology, medicine, and neuroscience.

Publications per year

2001–2023

21

Publications

21

Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans

Lina Luo, Jiri Aubrecht, Dingzhou Li et al. · PLoS ONE · 2018 · 175 citations · Full text

, , +16

l-NAME reduces infarction, neurological deficit and blood–brain barrier disruption following cerebral ischemia in mice

Dingzhou Li, Catherine Marchand‐Leroux, Nicole Croci et al. · European Journal of Pharmacology · 2002 · 65 citations

, , +17

Cross-site and cross-platform variability of automated patch clamp assessments of drug effects on human cardiac currents in recombinant cells

James Kramer, Herbert M. Himmel, Anders Lindqvist et al. · Scientific Reports · 2020 · 61 citations · Full text

, , +15

LF 16‐0687 Ms, a bradykinin B<sub>2</sub> receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia

Dingzhou Li, Isabelle Margaill, Bruno Palmier et al. · British Journal of Pharmacology · 2003 · 60 citations · Full text

, , +17

3-Aminobenzamide reduces brain infarction and neutrophil infiltration after transient focal cerebral ischemia in mice

J. Couturier, Dingzhou Li, Nicole Croci et al. · Experimental Neurology · 2003 · 52 citations

, , +16

1–5 of 21